Search Orphan Drug Designations and Approvals
-
Generic Name: | 6-Amino-9-[(3R)-1-(but-2-ynoyl)pyrrolidin-3-yl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one monohydrochloride |
---|---|
Date Designated: | 06/05/2017 |
Orphan Designation: | Treatment of chronic lymphocytic leukemia. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Gilead Sciences, Inc. 199 East Blaine Street Seattle, Washington 98102 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-